Explore our company news and media resources.

Contact us

Global Communications 
1000 Mylan Blvd. Canonsburg, PA 15317

+1. 724.514.1968

More info

Jul 27, 2021

Viatris (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas granted Mylan's motion to dismiss in a lawsuit brought against it and Pfizer by KPH Healthcare...

Jul 8, 2021

Viatris Inc. (NASDAQ: VTRS) plans to release its second quarter 2021 financial results on Monday, Aug. 9, before the open of the U.S. financial markets. Chief Executive Officer Michael Goettler,...

Jun 23, 2021

Viatris (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas ruled, in substantial part, in Mylan's favor on the company's summary judgment motion in the class...

May 25, 2021

Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021. Chief...

May 10, 2021

Reports First Quarter 2021 Financial Results - Total Revenue of $4.4 billion, U.S. GAAP net loss of $1.0 billion, Adjusted EBITDA of $1.6 billion, U.S. GAAP net cash provided by operating...

Browse press releases

Featured Stories

Discover Viatris: Delivering a Diverse and Robust Portfolio to Our Customers in Developed Markets

Our business model is fueled in part by our deep-market experience around the world including in our Developed Markets segment, which consists of North America and Europe.

Learn more

Featured News
Jul 14, 2021

Spanning 5 billion people around the world, Viatris’ Emerging Markets segment covers 125 countries and a diverse range of socioeconomic conditions and healthcare needs.

Mar 1, 2021

Highlighting a strong foundation and clear roadmap for the future at our inaugural Investor Day, Viatris leaders showcased our journey to build a new kind of healthcare company.

Aug 5, 2020

As a leading healthcare company, Viatris is committed to doing its part in support of public health needs amid the evolving COVID-19 pandemic.

Browse articles

In the News
Nov 17, 2020
VIATRIS™ started trading today on Nasdaq, and Executive Chairman Robert J. Coury and CEO Michael Goettler shared their excitement during an interview at Nasdaq’s global Client Experience Center, located in the heart of Times Square in New York City.
Stay Connected